BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2015

Jun 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2015-05-31

Reporting Person: Ajer Jeffrey Robert (SVP, Chief Commercial Of)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-05-31	Common Stock	F	413	$125.57	Disposed	38832	Direct
2015-06-01	Common Stock	S	377	$123.7582	Disposed	38455	Direct

Footnotes

F1: This transaction, which should have been reported on June 2, 2015, is being reported late due to an administrative oversight.

F2: Trade made pursuant to a 10b5-1 plan executed Mayy 11, 2015

F3: The price in column 4 is a weighted average price. The price actually received ranged from $123.06 to $124.18. Th reporting person shall provide to the issuer, and security holder of the issuer, or the SEC staff upon request, information regarding the number of shares sold at each price within the range.